Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Gross Profit: 2021-2024

Historic Gross Profit for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to $307.5 million.

  • Immunocore Holdings' Gross Profit rose 29.30% to $103.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.9 million, marking a year-over-year increase of 28.32%. This contributed to the annual value of $307.5 million for FY2024, which is 23.79% up from last year.
  • Immunocore Holdings' Gross Profit amounted to $307.5 million in FY2024, which was up 23.79% from $248.4 million recorded in FY2023.
  • Immunocore Holdings' Gross Profit's 5-year high stood at $307.5 million during FY2024, with a 5-year trough of $36.5 million in FY2021.
  • In the last 3 years, Immunocore Holdings' Gross Profit had a median value of $248.4 million in 2023 and averaged $243.0 million.
  • Data for Immunocore Holdings' Gross Profit shows a peak YoY surged of 374.93% (in 2022) over the last 5 years.
  • Immunocore Holdings' Gross Profit (Yearly) stood at $36.5 million in 2021, then skyrocketed by 374.93% to $173.3 million in 2022, then soared by 43.35% to $248.4 million in 2023, then increased by 23.79% to $307.5 million in 2024.